Skip to content

EV / sales at other companies

USANA Health Sciences logo
USANA Health SciencesUSNA
0.3×-0.3×
NuSkin Enterprises logo
NuSkin EnterprisesNUS
0.3×0.0×
Herbalife logo
HerbalifeHLF
0.6×0.0×
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
0.7×+0.4×
FitLife Brands, Inc. logo
FitLife Brands, Inc.FTLF
2.8×+0.5×
The Beauty Health Company logo
The Beauty Health CompanySKIN
0.1×+0.1×

Other financials

Income statement

See full
Revenue$43.7M-25.2%
Gross profit$34.5M-27.0%
Operating income$1.7M-58.6%
Net income$1.4M-60.7%
EPS (diluted)$0.11-57.7%

Balance sheet

See full
Cash & equivalents$12.5M-44.4%
Total debt$10.2M-17.4%
Total equity$33.3M-2.0%
Total assets$62.1M-19.6%

Cash flow

See full
Operating cash flow$5.0M+124%
CapEx$1.0M+205%
Free cash flow$4.0M+110%

Valuation

See full
Market cap$78.72M-51.4%
Enterprise value$76.45M-50.2%
P/E13.7×-2.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin78.1%-2.2pp
Operating margin3.4%-2.5pp
Net margin2.9%-1.2pp
FCF margin3.8%+1.1pp

Returns & leverage

See full
Return on equity17.1%-13.0pp
Debt / equity0.3×-0.1×
Current ratio+0.3×

Where this comes from

Calculated from Lifevantage Corporation’s reported figures.

Based on the most recent quarter.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifevantage Corporation's EV / sales?
Lifevantage Corporation (LFVN) reported EV / sales of 0.3× in Q1 2026.
How has Lifevantage Corporation's EV / sales changed year-over-year?
Lifevantage Corporation's EV / sales decreased by 65.1% year-over-year, from 0.8× to 0.3×.
What is the long-term trend for Lifevantage Corporation's EV / sales?
Over 4 years (2021 to 2025), Lifevantage Corporation's EV / sales has grown at a 11.0% compound annual growth rate (CAGR), from 0.4× to 0.6×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.